Organizational Facilitators and Barriers to Medication for Opioid Use Disorder Capacity Expansion and Use.
Organizational Facilitators and Barriers to Medication for Opioid Use Disorder Capacity Expansion and Use.
复制标题
DOI:
10.1007/s11414-020-09706-4
复制
发表时间:
2020-10
期刊:
影响因子:
--
通讯作者:
Molfenter T
中科院分区:
文献类型:
--
作者:
Jacobson N;Horst J;Wilcox-Warren L;Toy A;Knudsen HK;Brown R;Haram E;Madden L;Molfenter T
Medication for opioid use disorder (MOUD) is a key strategy for addressing the opioid use disorder crisis, yet gaps in MOUD provision impede this strategy’s benefits. The research reported here sought to understand what distinguishes low- and high-performing organizations in building and using capacity to provide MOUD. As part of a mixed methods MOUD implementation trial, semi-structured telephone interviews were conducted with personnel from low- and high- performing MOUD-providing organizations. Seventeen individuals from 17 organizations were interviewed. Findings demonstrate the importance of individual, organization, and community-level factors in supporting the building and use of MOUD capacity. Low- and high-performing organizations showed different patterns of facilitators and barriers during the implementation process. The key difference between low- and high-performing organizations was the level of organizational functioning. Better understanding of an organization’s assets and deficits at the individual, organizational, and community levels would allow decisionmakers to tailor their approaches to MOUD implementation.
登录
查看更多内容
影响因子:
3.3
作者:
Lynch, Sean;Sherman, Laura;Mattson, Margaret
通讯作者:
Mattson, Margaret
影响因子:
3.4
作者:
Knudsen, Hannah K.;Roman, Paul M.
通讯作者:
Roman, Paul M.
影响因子:
6
作者:
Jones, Christopher M.;McCance-Katz, Elinore F.
通讯作者:
McCance-Katz, Elinore F.
影响因子:
3.4
作者:
Gordon, Adam J.;Kavanagh, Greg;Liberto, Joseph
通讯作者:
Liberto, Joseph
影响因子:
3
作者:
Florence CS;Zhou C;Luo F;Xu L
通讯作者:
Xu L